Advertisement

Topics

Merck May Have Too Many Eggs in Its Keytruda Basket

20:00 EDT 15 Apr 2018 | BioSpace

Industry watchers and investors have shown some concern that Merck is abandoning other potentially lucrative areas of research to focus on exploiting every last bit of Keytruda’s potential

Original Article: Merck May Have Too Many Eggs in Its Keytruda Basket

NEXT ARTICLE

More From BioPortfolio on "Merck May Have Too Many Eggs in Its Keytruda Basket"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...